Tuberculosis (TB) remains one of the deadliest infectious diseases in the world, killing 1.5 million each year. Around 10 million people develop TB disease annually and 4,000 die of TB every day. [...]
Recommendations of TBVI for the European Commission call for evidence on: Antimicrobial resistance – Recommendation for greater action
To eliminate TB globally, new effective and affordable vaccines are needed. Please read the roadmap that lists the actions needed to accelerate TB R&.
Biofabri and Bharat Biotech partner to develop, manufacture and distribute a novel TB vaccine, MTBVAC
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: +31 320 277 550
